Drug Products Containing Ensulizole, Hypromellose, Meradimate, Octinoxate, and Octisalate — Labeling Enforcement Policy
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
June 3, 2003
April 28, 2020
4320b2a8-6f77-4cbf-8a20-7b9631fcf4fe
Related Documents
Nonclinical Safety Evaluation of Pediatric Drug Products
Guidance DocumentFebruary 15, 2006Center for Drug Evaluation and Research
Levothyroxine Sodium Products Enforcement of August 14, 2001 Compliance Date and Submission of New Applications
Guidance DocumentJuly 13, 2001Center for Drug Evaluation and Research
Integration of Dose-Counting Mechanisms into MDI Drug Products
Guidance DocumentMarch 13, 2003Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox